美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

克律克斯生物製藥

3.36

0.0000

成交量：- -

成交額：- -

市值：4.04億

市盈率：-4.49

高：3.36

開：3.36

低：3.36

收：3.36

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

克律克斯生物製藥

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.keryx.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Keryx Biopharmaceuticals is biopharmaceutical company focused on the acquisition, development and commercialization of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/KERX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KERX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KERX\",,,,,undefined,":{"symbol":"KERX","market":"US","secType":"STK","nameCN":"克律克斯生物製藥","latestPrice":3.36,"timestamp":1575925200000,"preClose":3.36,"halted":4,"volume":0,"delay":0,"floatShares":82153320,"shares":120375926,"eps":-0.749112,"marketStatus":"退市","change":0,"latestTime":"07-24 11:27:08 EDT","open":3.36,"high":3.36,"low":3.36,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.749112,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1753387200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":964756800000,"exchange":"NASDAQ","adjPreClose":3.36,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KERX\",,,,,undefined,":{"symbol":"KERX","floatShares":82153320,"roa":"--","roe":"--","lyrEps":-1.427327,"shares":120375926,"dividePrice":0,"high":3.36,"amplitude":0,"preClose":3.36,"low":3.36,"week52Low":2.47,"pbRate":"-7.46","week52High":5.98,"institutionHeld":0.9467,"latestPrice":3.36,"eps":-0.749112,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.749112,"open":3.36},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.keryx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0568},{"period":"3month","weight":0.1601},{"period":"6month","weight":0.0432},{"period":"1year","weight":0.1452},{"period":"ytd","weight":0.0821}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Keryx Biopharmaceuticals is biopharmaceutical company focused on the acquisition, development and commercialization of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.","exchange":"NASDAQ","name":"克律克斯生物製藥","nameEN":"Keryx Biopharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KERX\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KERX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-08","symbol":"KERX","fiscalQuarterEnding":"2018/09","expectedEps":-0.13,"name":null,"time":"盤後","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2018-08-08","symbol":"KERX","expectedEps":-0.14,"name":"克律克斯生物制药","time":"盤前","type":"earning","dateTimestamp":1533700800000,"reportTimeType":"pre","actualEps":-0.21},{"market":"US","date":"2018-05-10","symbol":"KERX","fiscalQuarterEnding":"2018/03","expectedEps":-0.19,"name":null,"time":"盤前","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2018-02-07","symbol":"KERX","fiscalQuarterEnding":"2017/12","expectedEps":-0.18,"name":null,"time":"盤前","type":"earning","dateTimestamp":1517979600000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2017-11-07","symbol":"KERX","expectedEps":-0.17,"name":"克律克斯生物制药","time":"","type":"earning","dateTimestamp":1510030800000,"reportTimeType":"","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KERX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KERX\",market:\"US\",delay:false,,,undefined,":{}}}